Follow
Bjoern Gohlke
Title
Cited by
Cited by
Year
The target landscape of clinical kinase drugs
S Klaeger, S Heinzlmeir, M Wilhelm, H Polzer, B Vick, PA Koenig, ...
Science 358 (6367), eaan4368, 2017
7372017
mVOC 2.0: a database of microbial volatiles
MC Lemfack, BO Gohlke, SMT Toguem, S Preissner, B Piechulla, ...
Nucleic acids research 46 (D1), D1261-D1265, 2018
3272018
SuperPred: update on drug classification and target prediction
J Nickel, BO Gohlke, J Erehman, P Banerjee, WW Rong, A Goede, ...
Nucleic acids research 42 (W1), W26-W31, 2014
3262014
Super Natural II—a database of natural products
P Banerjee, J Erehman, BO Gohlke, T Wilhelm, R Preissner, M Dunkel
Nucleic acids research 43 (D1), D935-D939, 2015
3232015
WITHDRAWN—a resource for withdrawn and discontinued drugs
VB Siramshetty, J Nickel, C Omieczynski, BO Gohlke, MN Drwal, ...
Nucleic acids research 44 (D1), D1080-D1086, 2016
2522016
TRPC6 G757D loss-of-function mutation associates with FSGS
M Riehle, AK Büscher, BO Gohlke, M Kaßmann, M Kolatsi-Joannou, ...
Journal of the American Society of Nephrology: JASN 27 (9), 2771, 2016
1082016
Chemical proteomics reveals ferrochelatase as a common off-target of kinase inhibitors
S Klaeger, B Gohlke, J Perrin, V Gupta, S Heinzlmeir, D Helm, H Qiao, ...
ACS chemical biology 11 (5), 1245-1254, 2016
972016
Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1
M Juneja, D Kobelt, W Walther, C Voss, J Smith, E Specker, ...
PLoS biology 15 (6), e2000784, 2017
872017
SuperDRUG2: a one stop resource for approved/marketed drugs
VB Siramshetty, OA Eckert, BO Gohlke, A Goede, Q Chen, ...
Nucleic acids research 46 (D1), D1137-D1143, 2018
842018
SynSysNet: integration of experimental data on synaptic protein–protein interactions with drug-target relations
J von Eichborn, M Dunkel, BO Gohlke, SC Preissner, MF Hoffmann, ...
Nucleic acids research 41 (D1), D834-D840, 2012
572012
SuperPred 3.0: drug classification and target prediction—a machine learning approach
K Gallo, A Goede, R Preissner, BO Gohlke
Nucleic Acids Research 50 (W1), W726-W731, 2022
552022
CancerResource—updated database of cancer-relevant proteins, mutations and interacting drugs
BO Gohlke, J Nickel, R Otto, M Dunkel, R Preissner
Nucleic Acids Research 44 (D1), D932-D937, 2016
382016
PROMISCUOUS 2.0: a resource for drug-repositioning
K Gallo, A Goede, A Eckert, B Moahamed, R Preissner, BO Gohlke
Nucleic Acids Research 49 (D1), D1373-D1380, 2021
272021
GenderMedDB: an interactive database of sex and gender-specific medical literature
S Oertelt-Prigione, BO Gohlke, M Dunkel, R Preissner, V Regitz-Zagrosek
Biology of sex Differences 5 (1), 1-5, 2014
242014
Real‐world evidence for preventive effects of statins on cancer incidence: A trans‐Atlantic analysis
BO Gohlke, F Zincke, A Eckert, D Kobelt, S Preissner, JM Liebeskind, ...
Clinical and Translational Medicine 12 (2), 2022
202022
Acyclovir has low but detectable influence on HLA-B* 57: 01 specificity without inducing hypersensitivity
IG Metushi, A Wriston, P Banerjee, BO Gohlke, AM English, A Lucas, ...
PloS one 10 (5), e0124878, 2015
182015
Sixty-one volatiles have phylogenetic signals across bacterial domain and fungal kingdom
MM Elmassry, MA Farag, R Preissner, BO Gohlke, B Piechulla, ...
Frontiers in Microbiology 11, 557253, 2020
162020
Exploring Activity Profiles of PAINS and Their Structural Context in Target–Ligand Complexes
VB Siramshetty, R Preissner, BO Gohlke
Journal of chemical information and modeling 58 (9), 1847-1857, 2018
152018
2D and 3D similarity landscape analysis identifies PARP as a novel off-target for the drug Vatalanib
BO Gohlke, T Overkamp, A Richter, A Richter, PT Daniel, B Gillissen, ...
BMC bioinformatics 16 (1), 1-9, 2015
142015
SuperPain—a resource on pain-relieving compounds targeting ion channels
BO Gohlke, R Preissner, S Preissner
Nucleic acids research 42 (D1), D1107-D1112, 2014
132014
The system can't perform the operation now. Try again later.
Articles 1–20